Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel I Feig

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Pediatric Nephrology (Berlin, Germany)|November 23, 2011
Association between left ventricular mass index and cardiac function in pediatric dialysis patientsPirouz Shamszad, Timothy C Slesnick, E O'Brian Smith, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|May 25, 2010
Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small childrenChristopher A Thomas, Brady S Moffett, Jeffrey L Wagner, et al.
The Journal of Pediatrics|February 14, 2013
Uric acid and the origins of hypertensionDaniel I Feig, Magdalena Madero, Diana I Jalal, et al.
American Journal of Hypertension|March 31, 2005
A unifying pathway for essential hypertensionRichard J Johnson, Bernardo Rodriguez-Iturbe, Duk-Hee Kang, et al.
Blood|December 7, 2016
Severe anemia early in life as a risk factor for sickle-cell kidney diseaseInmaculada Aban, Sujatha Baddam, Lee M Hilliard, et al.
Pediatric Nephrology (Berlin, Germany)|March 25, 2016
Prevalence of acute kidney injury during pediatric admissions for acute chest syndromeJeffrey D Lebensburger, Prasannalaxmi Palabindela, Thomas H Howard, et al.
Journal of the American Heart Association|November 6, 2017
Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled StudyLhanoo Gunawardhana, Lachy McLean, Henry A Punzi, et al.
Hypertension (Dallas, Tex. : 1979)|March 6, 2013
What are the key arguments against uric acid as a true risk factor for hypertension?Richard J Johnson, Laura G Sánchez-Lozada, Marilda Mazzali, et al.
Pediatric Nephrology (Berlin, Germany)|January 9, 2023
Adverse childhood experiences are associated with vascular changes in adolescents that are risk factors for future cardiovascular diseaseCailin E Kellum, Keri M Kemp, Sylvie Mrug, et al.
The American Journal of the Medical Sciences|March 21, 2017
Uric Acid Excretion Predicts Increased Blood Pressure Among American Adolescents of African DescentSylvie Mrug, Michal Mrug, Anjana Madan Morris, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Pediatric Nephrology (Berlin, Germany)|November 23, 2011
Association between left ventricular mass index and cardiac function in pediatric dialysis patientsPirouz Shamszad, Timothy C Slesnick, E O'Brian Smith, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|May 25, 2010
Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small childrenChristopher A Thomas, Brady S Moffett, Jeffrey L Wagner, et al.
The Journal of Pediatrics|February 14, 2013
Uric acid and the origins of hypertensionDaniel I Feig, Magdalena Madero, Diana I Jalal, et al.
American Journal of Hypertension|March 31, 2005
A unifying pathway for essential hypertensionRichard J Johnson, Bernardo Rodriguez-Iturbe, Duk-Hee Kang, et al.
Blood|December 7, 2016
Severe anemia early in life as a risk factor for sickle-cell kidney diseaseInmaculada Aban, Sujatha Baddam, Lee M Hilliard, et al.
Pediatric Nephrology (Berlin, Germany)|March 25, 2016
Prevalence of acute kidney injury during pediatric admissions for acute chest syndromeJeffrey D Lebensburger, Prasannalaxmi Palabindela, Thomas H Howard, et al.
Journal of the American Heart Association|November 6, 2017
Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled StudyLhanoo Gunawardhana, Lachy McLean, Henry A Punzi, et al.
Hypertension (Dallas, Tex. : 1979)|March 6, 2013
What are the key arguments against uric acid as a true risk factor for hypertension?Richard J Johnson, Laura G Sánchez-Lozada, Marilda Mazzali, et al.
Pediatric Nephrology (Berlin, Germany)|January 9, 2023
Adverse childhood experiences are associated with vascular changes in adolescents that are risk factors for future cardiovascular diseaseCailin E Kellum, Keri M Kemp, Sylvie Mrug, et al.
The American Journal of the Medical Sciences|March 21, 2017
Uric Acid Excretion Predicts Increased Blood Pressure Among American Adolescents of African DescentSylvie Mrug, Michal Mrug, Anjana Madan Morris, et al.
Pageof 7